Ionetix Corp / DE /

Ionetix Corp is a Delaware-incorporated radiopharmaceutical company focused on the production and distribution of cyclotron-generated radioisotopes used in nuclear medicine and positron emission tomography imaging. The company became publicly traded through a SPAC business combination and, as of its Form 10-Q filed with the SEC on May 20, 2026, continues to operate as a reporting public company in the healthcare and medical imaging sector. Ionetix supplies short-lived isotopes, including fluorine-18, to hospitals and imaging centers, positioning itself within the growing domestic radiopharmaceutical supply chain. For complete deal history, filing timelines, and SPAC analytics on Ionetix Corp and hundreds of other de-SPAC companies, sign up for full data access at SpacDesk.